Aptacef S 500mg/250mg Injection
Marketer
Zeeford Life Sciences
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Aptacef S 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be strictly under medical guidance; adhere to all scheduled doses. Complete the prescribed course regardless of symptom improvement; premature cessation may compromise efficacy. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms to your physician. Seek immediate medical attention for allergic reactions such as rash, itching, edema, or dyspnea. Inform your doctor of all current medications, especially if you are pregnant, breastfeeding, or have underlying health issues. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or dizziness. Ensure adequate rest, nutrition, and hydration for optimal recovery. Your physician may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Aptacef S 500mg/250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Aptacef S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Aptacef S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Aptacef S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Aptacef S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Aptacef S 500mg/250mg Injection works:
Aptacef S, a 500mg/250mg injectable formulation, unites the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thus optimizing ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Aptacef S 500mg/250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Aptacef S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Aptacef S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of treatment and until the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Aptacef S 500mg/250mg Injection could reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Aptacef S 500mg/250mg Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Aptacef S (500mg/250mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Medical consultation is advised. Dosage alterations for Aptacef S (500mg/250mg) injection are unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Aptacef S 500mg/250mg Injection :
Should you inadvertently skip a dose of Aptacef S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Aptacef S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently